- home
- about us
- Investment Approach
- Client Service Approach
- Market Analysis Summary
- Mission Statement
- Value Proposition
- Team Biographies
- Firm ADV PDFs
- Form CRS
- Firm Brochure-Part 2A of Form ADV
- Brochure Supplement Amit Stavinsky
- Brochure Supplement Frank Parks
- Brochure Supplement Dominick Savo
- Brochure Supplement Richard Mason
- Brochure Supplement Joe Estes
- Brochure Supplement Jonathan Ezra
- Statement Of Financial Strength
- Job Opportunities
- Letter to Clients
- member log-in
- contact us
Latest News about AXSM
Recent news which mentions AXSM
Billionaires Are Buying These 2 Ultra-High Yield Dividend Stocks Hand Over Fist. Are They Smart Buys for Your Portfolio?
April 16, 2024
From Motley Fool
2 Under-the-Radar Growth Stocks to Consider
April 10, 2024
From Motley Fool
From InvestorPlace
Tesla To $120? Here Are 10 Top Analyst Forecasts For Tuesday
March 26, 2024
From Benzinga
From Benzinga
Buying These Dirt-Cheap Stocks Could Be a Brilliant Move
March 23, 2024
From Motley Fool
What Analysts Are Saying About Axsome Therapeutics Stock
February 27, 2024
Tickers
AXSM
From Benzinga
3 Under-the-Radar Biotech Stocks With Upcoming Catalysts in 2024
February 26, 2024
From InvestorPlace
3 Biotech Stocks to Buy and Hold for the Next 10 Years
February 26, 2024
From Motley Fool
Axsome Therapeutics (AXSM) Q4 2023 Earnings Call Transcript
February 20, 2024
Tickers
AXSM
From Motley Fool
Neurology-Focused Axsome Therapeutics Reports Deeper Than Expected Q4 Loss, Updates Upcoming Pipeline Milestones
February 20, 2024
From Benzinga
Earnings Scheduled For February 20, 2024
February 20, 2024
From Benzinga
2 Stocks That Could Double Your Money in 5 Years
February 08, 2024
From Motley Fool
UBS Bullish On This Depression Drug Maker, Says Alzheimer's Agitation Data Is Attractive Catalyst
February 06, 2024
From Benzinga
Cramer Praises Asset Manager's 'Amazing Quarter,' But As For SolarEdge? 'Too Hard To Own'
January 26, 2024
From Benzinga
Axsome Depression Drug's Commercial Success, Pipeline Potential Undervalued, Analyst Says
January 25, 2024
From Benzinga
From Motley Fool
2 Biotech Stocks You Can Buy and Hold for the Next Decade
January 02, 2024
From Motley Fool
Prediction: These 3 Stocks Will Soar in 2024
January 01, 2024
From Motley Fool
3 Unstoppable Stocks to Buy Right Now
December 10, 2023
From Motley Fool
3 Biotech Stocks That Could Be Millionaire Makers
November 22, 2023
From Motley Fool
3 Growth Stocks to Buy Right Now Without Any Hesitation
November 11, 2023
From Motley Fool
3 Healthcare Stocks That Have More Than Doubled in Value Since the Fed Started Raising Interest Rates
November 09, 2023
From Motley Fool
Axsome's Strategy on Payer Coverage Slowly Pays Off, Depression Drug Sales Show Growth
November 06, 2023
Tickers
AXSM
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.